SEC Form 4 · accession 0001645627-17-000024
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 27, 2017
Accepted (ET)
Mar 29, 2017 · 3:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 27, 2017 | P | 1,000 | $0.0463 | A | 19,904,849 | D | |
| Common Stock | Mar 27, 2017 | P | 1,000 | $0.0452 | A | 19,905,849 | D | |
| Common Stock | Mar 28, 2017 | P | 2,000 | $0.039 | A | 19,907,849 | D | |
| Common Stock | Mar 28, 2017 | P | 2,000 | $0.0368 | A | 19,909,849 | D | |
| Common Stock | Mar 28, 2017 | P | 2,000 | $0.039 | A | 19,911,849 | D | |
| Common Stock | Mar 28, 2017 | P | 1,000 | $0.0359 | A | 19,912,849 | D | |
| Common Stock | Mar 28, 2017 | P | 1,000 | $0.0415 | A | 19,913,849 | D | |
| Common Stock | Mar 28, 2017 | P | 400 | $0.04 | A | 19,914,249 | D | |
| Common Stock | Mar 28, 2017 | P | 1,000 | $0.04 | A | 19,915,249 | D | |
| Common Stock | Mar 28, 2017 | P | 2,000 | $0.047 | A | 19,917,249 | D | |
| Common Stock | Mar 28, 2017 | P | 2,000 | $0.048 | A | 19,919,249 | D | |
| Common Stock | Mar 28, 2017 | P | 2,000 | $0.0465 | A | 19,921,249 | D | |
| Common Stock | Mar 28, 2017 | P | 1,000 | $0.0458 | A | 19,922,249 | D | |
| Common Stock | Mar 28, 2017 | P | 1,000 | $0.0465 | A | 19,923,249 | D | |
| Common Stock | Mar 28, 2017 | P | 2,000 | $0.0459 | A | 19,925,249 | D | |
| Common Stock | Mar 28, 2017 | P | 2,000 | $0.046 | A | 19,927,249 | D | |
| Common Stock | Mar 28, 2017 | P | 2,000 | $0.0459 | A | 19,929,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.0428 | A | 19,931,249 | D | |
| Common Stock | Mar 29, 2017 | P | 1,000 | $0.044 | A | 19,932,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.042 | A | 19,934,249 | D | |
| Common Stock | Mar 29, 2017 | P | 74 | $0.0392 | A | 19,934,323 | D | |
| Common Stock | Mar 29, 2017 | P | 4,926 | $0.041 | A | 19,939,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.041 | A | 19,941,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.042 | A | 19,943,249 | D |
Table II — derivative securities
No Table II lines on this filing.